AutoImmune-AIMM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AutoImmune-AIMM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom jones who wrote (122)	5/19/1997 11:36:00 AM
From: Dr. John M. de Castro	of 298

Positive results are the only thing that will move AIMM back up again. Right now, AIMM is selling at cash. That means that the market is valuating their technology at $0. The failed myloral and coloral trials have completely undercut the markets perception of the value of oral tolerance. For the stock to move up. The market will need evidence that there is any value at all in oral tolerance. The one short term hope is for positive results in the third coloral trial. The results are expected in July. Till then I'm not expecting much. But, I'm still holding. It's pretty much bottomed for the moment and who knows what will happen in the future. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next